Danish pension fund argues for capping Genmab CEO's pay
![Anders Schelde, chief investment and financial officer at AkademikerPension, hopes it will become common practice that companies halt bonus programs when the bonus-allocated stock wealth of CEOs reach a certain level. | Photo: PR/MP Pension](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article14543778.ece/ALTERNATES/schema-16_9/doc7nfeihyl6lec7jlkfya.jpg)
Chief Executive Officer at Genmab Jan van de Winkel is in a league of his own after many years of getting bonus-delegated Genmab shares. In total, he has around DKK 1.6bn (USD 233m) in Genmab stock.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.